Deletion of chromosomal region 6q 14-16 in prostate cancer

P.C. Verhagen; K.G. Hermans; M.O. Brok; W.M. van Weerden; M.G.J. Tilanus; R.A. de Weger; T.A. Boon; J. Trapman

Deletion of chromosomal region 6q 14-16 in prostate cancer

P.C. Verhagen, K.G. Hermans, M.O. Brok, W.M. van Weerden, M.G.J. Tilanus, R.A. de Weger, T.A. Boon, J. Trapman

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	142-147
Number of pages	6
Journal	International Journal of Cancer
Volume	102
Issue number	2
Publication status	Published - 2002

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Algemeen onderzoek
Biomedische technologie en medicijnen
Internal medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{b561b9e6ac86415793ff58d66cfb6d2f,

title = "Deletion of chromosomal region 6q 14-16 in prostate cancer",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Algemeen onderzoek, Biomedische technologie en medicijnen, Internal medicine",

author = "P.C. Verhagen and K.G. Hermans and M.O. Brok and \{van Weerden\}, W.M. and M.G.J. Tilanus and \{de Weger\}, R.A. and T.A. Boon and J. Trapman",

year = "2002",

language = "Undefined/Unknown",

volume = "102",

pages = "142--147",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley and Sons Inc",

number = "2",

}

TY - JOUR

T1 - Deletion of chromosomal region 6q 14-16 in prostate cancer

AU - Verhagen, P.C.

AU - Hermans, K.G.

AU - Brok, M.O.

AU - van Weerden, W.M.

AU - Tilanus, M.G.J.

AU - de Weger, R.A.

AU - Boon, T.A.

AU - Trapman, J.

PY - 2002

Y1 - 2002

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Algemeen onderzoek

KW - Biomedische technologie en medicijnen

KW - Internal medicine

M3 - Article

SN - 0020-7136

VL - 102

SP - 142

EP - 147

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 2

ER -